{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:46:02Z","timestamp":1787496362965,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.nmd.2025.105396","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:44:58Z","timestamp":1748720698000},"page":"105396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prevalence and prognostic impact of cardiac resonance abnormalities in myotonic dystrophy patients"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9227-0360","authenticated-orcid":false,"given":"Vincenzo","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7060-6938","authenticated-orcid":false,"given":"Alfredo","family":"Mauriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bottino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Marchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9o","family":"Pezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo","family":"Dellegrottaglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0008-6363(96)00163-0","article-title":"Cardiac disease in myotonic dystrophy","volume":"33","author":"Phillips","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.nmd.2025.105396_bib0002","first-page":"1241","article-title":"Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: p wave duration and dispersion analysis","volume":"19","author":"Russo","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.nmd.2025.105396_bib0003","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/genes13020367","article-title":"Myotonic dystrophies: a genetic overview","volume":"13","author":"Soltanzadeh","year":"2022","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.nmd.2025.105396_bib0004","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ahj.2003.08.008","article-title":"Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I","volume":"147","author":"Bhakta","year":"2004","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0005","article-title":"Cardiac involvement in myotonic dystrophy","volume":"5","author":"Khalighi","year":"2015","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"3","key":"10.1016\/j.nmd.2025.105396_bib0006","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000524734","article-title":"Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis","volume":"56","author":"Liao","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.nmd.2025.105396_bib0007","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tcm.2019.06.001","article-title":"Cardiovascular manifestations of myotonic dystrophy","volume":"30","author":"Wahbi","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.nmd.2025.105396_bib0008","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2459\/JCM.0000000000001476","article-title":"Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy","volume":"24","author":"Leali","year":"2023","journal-title":"J Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.nmd.2025.105396_bib0009","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.hrthm.2022.04.022","article-title":"HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders","volume":"19","author":"Groh","year":"2022","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.nmd.2025.105396_bib0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cardfail.2019.07.548","article-title":"Prevalence of left ventricular systolic dysfunction in myotonic dystrophy type 1: a systematic review","volume":"26","author":"Russo","year":"2020","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0011","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12968-014-0059-z","article-title":"Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study","volume":"16","author":"Petri","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0012","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1532-429X-14-48","article-title":"Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study","volume":"14","author":"Hermans","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0013","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mrm.22417","article-title":"QRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance","volume":"64","author":"Nazarian","year":"2010","journal-title":"Magn Reson Med"},{"issue":"7","key":"10.1016\/j.nmd.2025.105396_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004615","article-title":"Cardiac involvement in myotonic dystrophy type 2 patients with preserved ejection fraction","volume":"9","author":"Schmacht","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.nmd.2025.105396_bib0015","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.hrthm.2012.06.032","article-title":"Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging","volume":"9","author":"Turkbey","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nmd.2025.105396_bib0016","first-page":"11","article-title":"Rare disease: cardiac risk assessment with MRI in patients with myotonic dystrophy type 1","author":"Al\u00ec","year":"2020","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.nmd.2025.105396_bib0017","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00392-019-01414-0","article-title":"Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1","volume":"108","author":"Chmielewski","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"18","key":"10.1016\/j.nmd.2025.105396_bib0018","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/heartjnl-2015-308517","article-title":"Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy","volume":"102","author":"Choudhary","year":"2016","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.nmd.2025.105396_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009100","article-title":"Comprehensive Cardiac Magnetic resonance for assessment of cardiac involvement in myotonic muscular dystrophy type 1 and 2 without known cardiovascular disease","volume":"12","author":"Luetkens","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12968-021-00812-6","article-title":"Spuler S.et al. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study","volume":"23","author":"Blaszczyk","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"issue":"21","key":"10.1016\/j.nmd.2025.105396_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030229","article-title":"Prognostic utility of cardiovascular magnetic resonance\u2013Based phenotyping in patients with muscular dystrophy","volume":"12","author":"Kashyap","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0022","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12968-019-0535-6","article-title":"Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality","volume":"21","author":"Cardona","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00246-021-02686-y","article-title":"Diagnostic and prognostic value of cardiovascular magnetic resonance in neuromuscular cardiomyopathies","volume":"43","author":"Almogheer","year":"2022","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105396_bib0024","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2016.4145","article-title":"Left ventricular dysfunction and conduction disturbances in patients with myotonic muscular dystrophy type I and II","volume":"2","author":"Tanawuttiwat","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"15","key":"10.1016\/j.nmd.2025.105396_bib0025","article-title":"Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy","author":"Abati","year":"2024","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2025.105396_bib0026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11897-021-00521-2","article-title":"Role of CMR imaging in diagnostics and evaluation of cardiac involvement in muscle dystrophies","volume":"18","author":"Blaszczyk","year":"2021","journal-title":"Curr Heart Fail Rep"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0027","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (SCMR) and CMR working group of the european society of cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.nmd.2025.105396_bib0028","first-page":"63","article-title":"Comprehensive cardiovascular management of myotonic dystrophy type 1 patients: a report from the Italian Neuro-Cardiology Network","volume":"11","author":"Russo","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"issue":"4","key":"10.1016\/j.nmd.2025.105396_bib0029","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nmd.2018.01.010","article-title":"Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1","volume":"28","author":"Russo","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2025.105396_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nmd.2021.01.002","article-title":"Prevalence of atrial fibrillation in myotonic dystrophy type 1: a systematic review","volume":"31","author":"Russo","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.nmd.2025.105396_bib0031","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/pace.12970","article-title":"Which is the true epidemiology of atrial fibrillation in myotonic dystrophy type 1 patients?","volume":"39","author":"RUSSO","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105396_bib0032","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijcard.2012.11.076","article-title":"The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes","volume":"168","author":"Sansone","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0033","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13760-018-1052-3","article-title":"Heart involvement in patients with myotonic dystrophy type 2","volume":"119","author":"Peric","year":"2019","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"10.1016\/j.nmd.2025.105396_bib0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10741-022-10235-9","article-title":"Clinical application of CMR in cardiomyopathies: evolving concepts and techniques","volume":"28","author":"Merlo","year":"2022","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1016\/j.nmd.2025.105396_bib0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.08.037","article-title":"Cardiac manifestations of myotonic dystrophy type 1","volume":"160","author":"Petri","year":"2012","journal-title":"Int J Cardiol"},{"issue":"40","key":"10.1016\/j.nmd.2025.105396_bib0036","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.nmd.2025.105396_bib0037","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.tcm.2017.12.006","article-title":"ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies","volume":"28","author":"Russo","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.nmd.2025.105396_bib0038","first-page":"1148","article-title":"Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation","volume":"24","author":"Russo","year":"2022","journal-title":"EP Eur"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625001233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625001233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T18:41:42Z","timestamp":1754505702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625001233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"alternative-id":["S0960896625001233"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105396","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and prognostic impact of cardiac resonance abnormalities in myotonic dystrophy patients","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105396"}}